Studies toward the Synthesis of Colletotrichamide A: Construction of the C19–C30 Segment of the Molecule

Nemilikonda Sravan Kumar; Radhakrishna Gattu; B. Janaki Ramulu; Subhash Ghosh

doi:10.1055/a-2373-0372

Synlett, Table of Contents

Synlett 2024; 35(20): 2559-2663
DOI: 10.1055/a-2373-0372

letter

Special Issue to Celebrate the 75th Birthday of Prof. B. C. Ranu

Studies toward the Synthesis of Colletotrichamide A: Construction of the C19–C30 Segment of the Molecule

Authors

Nemilikonda Sravan Kumar

^aDepartment of Organic Synthesis and Process Chemistry, CSIR - Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500 007, India
Radhakrishna Gattu

^aDepartment of Organic Synthesis and Process Chemistry, CSIR - Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500 007, India
B. Janaki Ramulu

^aDepartment of Organic Synthesis and Process Chemistry, CSIR - Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500 007, India
Subhash Ghosh

^aDepartment of Organic Synthesis and Process Chemistry, CSIR - Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500 007, India

^bAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India

Abstract

All articles of this category

Abstract

A synthesis of the C19–C30 segment of the neuroprotective natural product colletotrichamide A has been achieved by performing a Sonogashira coupling of two advanced intermediate fragments: a vinyl iodide and an alkyne. A Maruoka–Keck allylation, an Evans syn-aldol reaction, and Takai olefinations served as the key steps in the synthesis of the vinyl iodide intermediate, whereas glycosidation and Ohira–Bestmann reactions were used as the pivotal steps for accessing the advanced alkyne intermediate.

Key words:

colletotrichamide A - neurodegenerative disease - Maruoka–Keck allylation - Evans syn-aldol reaction - glycosidation - Sonogashira reaction

Full Text

References

References and Notes
1 Heemels M.-T. Nature 2016; 539: 179
2 GBD 2015 Neurological Disorders Collaborator Group 2017; 16: 877
3 Kumar A, Singh AA, Ekavali Ekavali. Pharmacol. Rep. 2015; 67: 195
4 Bang S, Lee C, Kim S, Song HJ, Kang SK, Deyrup ST, Nam J.-S, Xia X, Shim HS. J. Org. Chem. 2019; 84: 10999

5a Chen J, Jian Y, Yan J, Xu C, Ye T. Molecules 2023; 28: 7194
5b Fujii K, Ikai Y, Oka H, Suzuki M, Hrada K. Anal. Chem. 1997; 69: 5146

6a Hanawa H, Hashimoto T, Maruoka K. J. Am. Chem. Soc. 2003; 125: 1708
6b Yadav JS, Suresh B, Srihari P. Eur. J. Org. Chem. 2015; 5856
6c de Fátima Â, Kohn LK, Antônio MA, de Carvalho JE, Pilli RA. Bioorg. Med. Chem. 2005; 13: 2927

7 Yadav JS, Dhara S, Mohapatra DK. Tetrahedron 2017; 73: 1358
8 Cachoux F, Isarno T, Wartmann M, Altmann K.-H. Angew. Chem. Int. Ed. 2005; 44: 7469
9 Davies JA, Bull FM, Walker PD, Weir AN. M, Lavigne R, Masschelein J, Simpson TJ, Race PR, Crump MP, Willis CL. Org. Lett. 2020; 22: 6349
10 Wang G, Yin N, Negishi E.-i. Chem. Eur. J. 2011; 17: 4118
11 Evans DA, Bartroli J, Shih TL. J. Am. Chem. Soc. 1981; 103: 2127

12a Evans DA, Ennis MD, Mathre DJ. J. Am. Chem. Soc. 1982; 104: 1737
12b Evans DA, Trenkle WC, Zhang J, Burch JD. Org. Lett. 2005; 7: 3335

13 Lafontaine JA, Provencal DP, Gardelli C, Leahy JW. J. Org. Chem. 2003; 68: 4215
14 Peng Z.-H, Woerpel KA. J. Am. Chem. Soc. 2003; 125: 6018
15 Ramachandran PV, Srivastava A, Hazra D. Org. Lett. 2007; 9: 157

16a Takai K, Nitta K, Utimoto K. J. Am. Chem. Soc. 1986; 108: 7408
16b Ghosh AK, Kassekert LA, Bungard JD. Org. Biomol. Chem. 2016; 14: 11357

17 Loscher S, Schobert R. Chem. Eur. J. 2013; 19: 10619

18a Lawandi J, Rocheleau S, Moitessier NJ. Tetrahedron 2011; 67: 8411
18b Yang S, Liu Q, Zhang G, Zhang X, Zhao Z, Lei P. J. Org. Chem. 2018; 83: 5897

19a Collins JA, Gerry CJ, Duncan MM. Synlett 2019; 30: 2193
19b Asress KH, Wang C.-C. Beilstein J. Org. Chem. 2019; 15: 2990

20 Shepard MS, Carreira EM. J. Am. Chem. Soc. 1997; 119: 2597
21 Borowski D, Oechsner RM, Jürgens E, Ziegler T. Eur. J. Org. Chem. 2017; 4490
22 Itoh K, Huang Z, Liu H.-w. Org. Lett. 2007; 9: 879
23 Ryu J.-H, Lee E, Lim Y.-b, Lee M. J. Am. Chem. Soc. 2007; 129: 4808

24a El Sous M, Ganame D, Tregloan PA. Rizzacasa M. A. Org. Lett. 2004; 6: 3001
24b Olpp T, Brückner R. Angew. Chem. Int. Ed. 2006; 45: 4023

25a Sonogashira K, Tohda Y, Hagihara N. Tetrahedron Lett. 1975; 16: 4467
25b Zhou J, Gao B, Xu Z, Ye T. J. Am. Chem. Soc. 2016; 138: 6948

26 (5R,6S)-5-[(2S,3S,4E,8R)-2-[(4-Methoxybenzyl)oxy]-3-methyl-8-({(2R,3S,4S,5R,6R)-3,4,5-tris(benzyloxy)-6-[(benzyloxy)methyl]tetrahydro-2H-pyran-2-yl}oxy)non-4-en-6-yn-1-yl]-2,2,3,3,6,10,10-heptamethyl-9,9-diphenyl-4,8-dioxa-3,9-disilaundecane (28) Pd(PPh₃)₄ (231 mg, 0.20 mmol) and CuI (152 mg, 0.80 mmol) were added to a solution of vinyl iodide 9 (300 mg, 0.40 mmol), alkyne 10 (271 mg, 0.46 mmol), and Et₃N (86 μL, 0.60 mmol) in anhyd THF (10 mL) under argon at rt, and the mixture was stirred at rt for 5 h. The reaction was then quenched with sat. aq of NH₄Cl (15 mL) and the mixture was extracted with EtOAc (3 × 20 mL). The combined organic extracts were washed with brine (10 mL), dried (Na₂SO₄), and concentrated in vacuo. The residue was purified by gel column chromatography [silica gel (100–200 mesh), 10% EtOAc–hexane] to give a white solid; yield: 415 mg (87%); R_f = 0.5 (silica gel, 20% EtOAc–hexane); [α]_D ²⁵ –5.9 (c 1.2, CHCl₃). IR (neat): 3065, 3031, 2955, 2928, 1612, 1587, 1513, 1438, 1249, 1105, 1066, 824, 738 cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 7.72–7.68 (m, 1 H), 7.65–7.60 (m, 4 H), 7.56–7.50 (m, 1 H), 7.49–7.45 (m, 2 H), 7.42–7.31 (m, 9 H), 7.29–7.25 (m, 10 H), 7.24–7.22 (m, 2 H), 7.21–7.17 (m, 3 H), 6.86–6.80 (m, 2 H), 6.20 (dd, J = 16.0, 7.1 Hz, 1 H), 5.47 (d, J = 16.0 Hz, 1 H), 4.99 (d, J = 12.4 Hz, 1 H), 4.88 (q, J = 7.7 Hz, 2 H), 4.72 (q, J = 6.3 Hz, 1 H), 4.67–4.43 (m, 6 H), 4.38 (s, 2 H), 4.22 (t, J = 6.1 Hz, 1 H), 3.93–3.84 (m, 2 H), 3.80–3.77 (m, 2 H), 3.75 (s, 3 H), 3.61 (dd, J = 10.0, 7.5 Hz, 1 H), 3.53 (dd, J = 9.3, 2.7 Hz, 1 H), 3.50–3.40 (m, 3 H), 2.48 (t, J = 7.7 Hz, 1 H), 2.34 (t, J = 7.5 Hz, 1 H), 1.95–1.89 (m, 1 H), 1.70–1.67 (m, 1 H), 1.49 (d, J = 6.6 Hz, 3 H), 1.04 (s, 9 H), 0.93 (dd, J = 6.7, 2.2 Hz, 3 H), 0.88 (d, J = 6.4 Hz, 3 H), 0.83 (s, 9 H), 0.00 (s, 3 H), –0.02 (s, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 159.1, 147.8, 138.9, 138.6, 138.5, 138.3, 135.6, 135.4, 135.3, 135.2, 133.9, 133.8, 131.8, 131.0, 130.3, 129.7, 129.3, 128.5, 128.4, 128.4, 128.3, 128.2, 128.1, 128.0, 127.7, 127.6, 127.4, 127.3, 113.8, 108.9, 99.0, 87.7, 84.2, 82.6, 78.8, 76.2, 75.2, 74.9, 74.1, 74.0, 73.6, 71.5, 71.3, 70.5, 69.7, 66.0, 65.1, 55.3, 41.1, 39.6, 34.0, 27.0, 26.0, 22.3, 19.3, 18.1, 13.6, 12.3, –4.0, –4.2. MS (ESI): m/z = 1268 [M + NH₄]⁺. HRMS (ESI): m/z [M + NH₄]⁺ calcd for : 1268.7042; found: 1268.7081

Supplementary Material

Supporting Information (PDF)